The meta-analysis of genome-wide association studies

Briefings in Bioinformatics

Volumn 12, Issue 3, 2011, Pages 259-269

  Thompson, John R ^a   Attia, John ^b   Minelli, Cosetta ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c INSTITUTE FOR RENEWABLE ENERGY   (Italy)

Author keywords

Confounding; Genome wide association studies; Genome wide significance; Heterogeneity; Meta analysis

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; GENETIC ASSOCIATION; GENETICS; GENOME; HUMAN; META ANALYSIS; POPULATION GENETICS;

GENETICS, POPULATION; GENOME; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MODELS, GENETIC;

EID: 79955771434     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbr020     Document Type: Article

References (73)

1. Egger M, Schneider M, Smith GD. Spurious precision? Meta-analysis of observational studies. BMJ 1998;316: 140-14.
2. Elston RC, Olsen JM, Palmer L. Biostatistical Genetics and Genetic Epidemiology. Wiley, Chichester, 2002.
3. Thomas DC. Statistical Methods in Genetic Epidemiology. Oxford University Press, New York, 2004.
4. Ziegler A, König IR. A Statistical Approach to Genetic Epidemiology: Concepts and Applications. Wiley, Weinheim, 2010.
5. Sutton AJ, Abrams KR, Jones DR, et al. Methods for Meta-analysis inMedical Research. Wiley, Chichester, 2000.
6. Borenstein M, Hedges LV, Higgins JPT, et al. Introduction to Meta-analysis. Wiley, Chichester, 2009.
7. Sterne J. Meta-analysis in Stata. Stata Press, College Station, Texas, 2009.
8. Wang WYS, Barratt BJ, Clayton DG, et al. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005;6:109-18.
9. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet 2006;7:781-91.
10. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus uncertainty and challenges. Nat Rev Genet 2008;9: 356-69.
11. Ziegler A, König IR, Thompson JR. Biostatistical aspects of genome-wide association studies. Biom J 2008;50:8-28.
12. Moonesinghe R, Khoury MJ, Liu T, et al. Required sample size and non-replicability thresholds for heterogeneous genetic associations. Proc Natl Acad Sci USA 2008;105:617-22.
13. Spencer CCA, Su Z, Donnelly P, et al. Designing genome-wide association studies: Sample size power imputation and the choice of genotyping chip. PLoS Genetics 2009;5:e1000477.
14. de Bakker PIW, Ferreira MAR, Jia X, et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. HumMol Genet 2008;17:R122-8.
15. Zeggini E, Ioannidis JPA. Meta-analysis in genome-wide association studies. Pharmacogenomics 2009;10:191-201.
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR Statist Soc 1995;57:289-300.
17. Seminara D, Khoury MJ, O'Brien TR, etal. The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology 2007;18:1-8.
18. Minelli C, Thompson JR, Abrams KR, et al. The quality of meta-analyses of genetic association studies: a review with recommendations. Am J Epidemiol 2009;170:1333-43.
19. Ioannidis JPA, Thomas G, Daly MJ. Validating augmenting and refining genome-wide association signals. Nat Rev Gen 2009;10:318-29.
20. Ioannidis JPA, Patsopoulos NA, Evangelou E. Heterogeneity in meta-analyses of genome-wide association investigations. PLoS One 2007;2:e841.
21. Kraft P, Zeggini E, Ioannidis JPA. Replication in genome-wide association studies. Stat Sci 2009;24:561-73.
22. Greene CS, Penrod NM, Williams SM, et al. Failure to replicate a genetic association may provide important clues about genetic architecture. PLoS One 2009;4:e5639.
23. Anonymous. Freely associating. Nat Genet 1999;22:1-2.
24. Chanock SJ, Manolio T, Boehnke M, et al. Replicating genotype-phenotype associations. Nature 2007;447:655-60.
25. Skol AD, Scott LJ, Abecasis GR, et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006;38: 209-13.
26. Thomas DC, Casey G, Conti DV, et al. Methodological issues in multistage genome-wide association studies. Stat Sci 2009;4:414-29.
27. Cantor RM, Lange K, Sinsheimer JS. Prioritizing GWAS results: a review of statistical methods and recommendations for their application. Am J Hum Genet 2010;86:6-22.
28. Roeder K, Wasserman L. Genome-wide significance levels and weighted hypothesis testing. Stat Sci 2009;24: 398-413.
29. Voight BF, Pritchard JK. Confounding from cryptic relatedness in case-control association studies. Plos Genetics 2005;1:e32.
30. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet 2010;11: 499-51.
31. Thakkinstian A, Thompson J, Minelli C, et al. Choosing between per-genotype per-allele and trend approaches for initial detection of gene-disease association. J Appl Statist 2009;36:633-46.
32. Zheng G, Joo J, Zaykin D, et al. Robust tests in genomewide scans under incomplete linkage disequilibrium. Stat Sci 2009;24:503-16.
33. Lin DY, Zeng D. Meta-analysis of genome-wide association studies: no efficiency gain in using individual participant data. Genet Epidemiol 2010;34:60-66.
34. Karp DR, Carlin S, Cook-Deegan R, et al. Ethical and practical issues associated with aggregating databases. PLoS Med 2008;5:e190.
35. Pfeiffer R, Gail M, Pee D. On combining data from genome-wide association studies to discover diseaseassociated SNPs. Stat Sci 2009;24:547-56.
36. Lebrec J, Stijnen T, van Houwelingen H. Dealing with heterogeneity between cohorts in genomewide SNP association studies. Stat Appl Genet Mol Biol 2010;9:1-20.
37. Lambert P, Sutton A, Abrams K, Jones D. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol 2002; 55:86-96.
38. Berlin J, Santanna J, Schmid C, et al. Individual patientversus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Statist Med 2002;21:371-87.
39. McKinney BA, Reif DM, Ritchie MD, et al. Machine learning for detecting gene-gene interations: a review. Appl Bioinform 2006;5:77-88.
40. Trégouët D-A, König IR, Erdmann J, et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009;41:283-5.
41. Ioannidis JP, Ntzani EE, Trikalinos TA, et al. Replication validity of genetic association studies. Nat Genet 2001;29: 306-9.
42. Clarke GM, Carter KW, Palmer LK, et al. Fine mapping versus replication in while-genome association studies. Am J Hum Genet 2007;81:995-1005.
43. DerSimonian R, Laird N. Meta-analysis in clinical trials. Contr Clin Trials 1986;7:177-88.
44. Greenland S. Invited commentary: A critical look at some popular meta-analytic methods. Am J Epidemiol 1994;140: 290-6.
45. Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Statist Soc A 2009;172:137-59.
46. Storey JS, Tibshirani R. Statistical significance for genomewide studies. PNAS 2003;100:9440-5.
47. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994;309: 1351-5.
48. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
49. Ioannidis JPA. Non-replication and inconsistency in the genome-wide association setting. Hum Hered 2007;64: 203-13.
50. Lin P-I, Vance JM, Pericak-Vance MA, et al. No gene is an island: the flip-flop phenomenon. AmJHumGenet 2007;80: 531-8.
51. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001;358:1356-60.
52. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003;361:598-604.
53. Clayton DG, Walker NM, Smyth DJ, et al. Population structure differential bias and genomic control in a large-scale case-control association study. Nat Genet 2005; 37:1243-6.
54. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-9.
55. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-17.
56. Clayton D. P-values false discovery rates and Bayes factors: how should we assess the 'significance' of genetic associations? Ann Hum Gen 2003;67:630.
57. Dudbridge F, Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet Epidemiol 2008;32:227-34.
58. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-8.
59. Rice TK, Schork NJ, Rao DC. Methods for handling multiple testing. Adv Genet 2008;60:293-308.
60. Zollner S, Pritchard JK. Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am J Hum Genet 2007;80:605-15.
61. Ghosh A, Zou F, Wright F A. Estimating odds ratios in genome scans: an approximate conditional likelihood approach. Am J Hum Genet 2008;82:1064-74.
62. Bowden J, Dudbridge F. Unbiased estimation of odds ratios: combining genomewide association scans with replication studies. Genet Epidemiol 2009;33:406-18.
63. Zhong H, Prentice RL. Correcting 'winner's curse' in odds ratios from genome-wide association findings for major complex human diseases. Genet Epidemiol 2010;34:78-91.
64. Wellcome Trust Case-Control Consortium. Genome-wide association study of 14000 cases of seven common diseases and 3000 shared controls. Nature 2007;447:661-78.
65. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. NEnglJMed 2007; 357:443-53.
66. Stephens M, Balding DJ. Bayesian statistical methods for genetic association studies. Nat Rev Genet 2009;10:681-90.
67. Wakefield J. Bayes factors for genome-wide association studies: comparison with P-values. Genet Epidemiol 2009;33: 79-86.
68. Afilalo J, Duque G, Steele R, et al. Statins for secondary prevention in elderly patients A hierarchical Bayesian meta-analysis. J Am Coll Cardiol 2008;51:37-45.
69. Berry D, Wathen JK, Newell M. Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality. Clin Trials 2009;628-41.
70. Conlon EM, Postier BL, Methe BA, et al. Hierarchical Bayesian meta-analysis models for cross-platform microarray studies. J Appl Stat 2009;36:1067-85.
71. De la Cruz O, Wen X, Ke B, et al. Gene region and pathway level analyses in whole-genome studies. Genet Epidemiol 2010;34:222-31.
72. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008;299:1335-44.
73. Devlin B, Roeder K. Genomic control for association studies. Biometrics 1999;55:997-1004.